CLOSE X
GO

HDFC Pharma and Healthcare Fund-Reg(G)

very highequitypharma & health care
16.05 -0.13(-0.83%) NAV as on 29 Apr 2025
0.8 % 1 M
27.51 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.03

As on 31 Mar, 2025
age-icon Age :

1 yrs 6 m

Since 04 10 ,2023
exit_load Exit Load :

1%

aum AUM :

1,634.08 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

6.99

Min_Investment Min. Investment :

SIP 100 & Lumpsum 100

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Nikhil Mathur

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2025
Others 2.72 %
Equity 97.28 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.84 %
Divi's Laboratories Ltd.8.55 %
Cipla Ltd.7.19 %
Lupin Ltd.5.43 %
Max Healthcare Institute Ltd.4.91 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs73.47
Hospital & Healthcare Services21.02
Medical Equipment/Supplies/Accessories1.76
Business Support1.04
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-2025
NAV in Rs (as on 31-Mar-2025)12.2915.92
Net Assets(Rs Crores) (as on 31-Mar-2025) 800.65 1634.08
Scheme Returns(%)(Absolute)23.3028.35
B'mark Returns(%)(Absolute)NANA
Category Rank66/901/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

HDFC Pharma and Healthcare Fund-Reg(G)Very HighEquity16.05-0.13(-0.83%)NAV As on 29 Apr, 202504-Oct-2023Inception Date1,634.08AUM In Cr.27.51%1YNA%3YNA%5Y35.48%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.27-0.28(-0.75%)NAV As on 29 Apr, 202513-Jul-2018Inception Date4,914.64AUM In Cr.20.77%1Y24.16%3Y25.01%5Y21.35%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity420.24-2.22(-0.53%)NAV As on 29 Apr, 202514-Jul-1999Inception Date3,610.51AUM In Cr.20.63%1Y23.83%3Y24.41%5Y16.32%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.30-0.28(-0.93%)NAV As on 29 Apr, 202528-Dec-2015Inception Date1,183.65AUM In Cr.15.75%1Y20.26%3Y21.78%5Y12.19%Since Inception
Nippon India Pharma Fund(G)Very HighEquity496.60-3.09(-0.62%)NAV As on 29 Apr, 202505-Jun-2004Inception Date8,080.97AUM In Cr.15.44%1Y20.01%3Y22.50%5Y20.53%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors